Cargando…

MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung

The differential diagnosis of epithelioid mesothelioma from lung adenocarcinoma and squamous cell carcinoma requires the positive and negative immunohistochemical markers of mesothelioma. The IMIG guideline has suggested the use of Calretinin, D2–40, WT1, and CK5/6 as mesothelial markers, TTF-1, Nap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mawas, Amany Sayed, Amatya, Vishwa Jeet, Kushitani, Kei, Kai, Yuichiro, Miyata, Yoshihiro, Okada, Morihito, Takeshima, Yukio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760602/ https://www.ncbi.nlm.nih.gov/pubmed/29317712 http://dx.doi.org/10.1038/s41598-017-18545-x

Ejemplares similares

Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia
por: Kushitani, Kei, et al.
Publicado: (2018)

miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma
por: Suzuki, Rui, et al.
Publicado: (2018)

Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung
por: Kai, Yuichiro, et al.
Publicado: (2021)

Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1
por: Fujii, Yutaro, et al.
Publicado: (2022)

Downregulation of FTL decreases proliferation of malignant mesothelioma cells by inducing G(1) cell cycle arrest
por: Kambara, Takahiro, et al.
Publicado: (2022)

Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27(Kip1)
por: Endo, Ihiro, et al.
Publicado: (2022)

Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma
por: Ito, Masaoki, et al.
Publicado: (2023)

Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report
por: Makidono, Kimitaka, et al.
Publicado: (2021)

Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor
por: Naka, Tomoaki, et al.
Publicado: (2022)

Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer
por: Furukawa, Takaoki, et al.
Publicado: (2015)

Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size
por: Ito, Masaoki, et al.
Publicado: (2021)

Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer
por: Kagimoto, Atsushi, et al.
Publicado: (2021)

Usefulness of serum S100A4 and positron‐emission tomography on lung cancer accompanied by interstitial pneumonia
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Increased risk of recurrence in resected EGFR‐positive pN0M0 invasive lung adenocarcinoma
por: Ito, Masaoki, et al.
Publicado: (2018)

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma
por: AMATYA, VISHWA JEET, et al.
Publicado: (2012)

Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma
por: Kagimoto, Atsushi, et al.
Publicado: (2020)

Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing
por: Ito, Masaoki, et al.
Publicado: (2017)

Metachronous Double Pituitary Adenoma with Altered Transcriptional Factor Profile: A Case Report and Literature Review
por: TAGUCHI, Akira, et al.
Publicado: (2021)

Primary intrahepatic malignant epithelioid mesothelioma
por: Perysinakis, Iraklis, et al.
Publicado: (2014)

The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion
por: Halimi, Monireh, et al.
Publicado: (2019)

Application of immunohistochemistry in diagnosis and management of malignant mesothelioma
por: Chapel, David B., et al.
Publicado: (2020)

Primary Small Intestinal Sarcomatoid Carcinoma: Report of a Rare Case and Literature Review
por: Karakuchi, Nozomi, et al.
Publicado: (2021)

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
por: Creaney, J, et al.
Publicado: (2008)

Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report
por: Hamai, Yoichi, et al.
Publicado: (2012)

Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report
por: Miyata, Takashi, et al.
Publicado: (2019)

Histological comparison of malignant epithelioid mesothelioma in young and adult cattle
por: KAWASHIMA, Yuuto, et al.
Publicado: (2021)

Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma
por: Ollila, Hely, et al.
Publicado: (2022)

Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma
por: Saddozai, Umair Ali Khan, et al.
Publicado: (2022)

Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry
por: Sandeck, Helmut P, et al.
Publicado: (2010)

Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT
por: Kaichi, Yoko, et al.
Publicado: (2018)

Effect of bevacizumab against cystic components of brain tumors
por: Yamasaki, Fumiyuki, et al.
Publicado: (2019)

Bladder perivascular epithelioid cell neoplasm: The importance of immunohistochemistry in the diagnosis of an unusual neoplasm
por: De Noon, Solange, et al.
Publicado: (2021)

Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review
por: Ito, Masaoki, et al.
Publicado: (2023)

RhoA and vigilin are candidates for immunohistochemical markers for epithelioid malignant mesothelioma
por: Hiratsuka, Takuya, et al.
Publicado: (2022)

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
por: Ghanim, B, et al.
Publicado: (2015)

Isolated Neurohypophysial Sarcoidosis Involving the Cavernous Sinus Mimicking a Malignant Tumor
por: KINOSHITA, Yasuyuki, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study
por: Fujimoto, Nobukazu, et al.
Publicado: (2020)

Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity
por: Brcic, Luka, et al.
Publicado: (2021)

KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma
por: Vannucchi, Margherita, et al.
Publicado: (2023)

Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair
por: Ganzinelli, Monica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fsu56jr1ku29db2pa3od9g1nek